Skip to content
healthcare.dev

Pseudoephedrine Hydrochloride

NDC 0363-0204, Pseudoephedrine Hydrochloride, tablet, film coated, extended release, from Walgreen Company.

Product NDC
0363-0204
Status
Listed
Labeler
Walgreen Company
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA077442
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0363-0204 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0363-0204-200036302042020 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0363-0204-20)
0363-0204-690036302046910 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0363-0204-69)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0363-0204 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0363-0204 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0363-0204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.